(Q55479812)

12 July 2018

title

1314 In pulmonary tuberculosis. (English)

1 reference

12 July 2018

1 reference

SOMNER AR

1

1 reference

12 July 2018

ROSS JD

2

1 reference

12 July 2018

MACLEOD HM

3

1 reference

12 July 2018

STEWART SM

4

1 reference

12 July 2018

HORNE NW

5

1 reference

12 July 2018

CROFTON JW

6

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 February 1959

1 reference

12 July 2018

published in

The BMJ

1 reference

12 July 2018

volume

1

1 reference

12 July 2018

issue

5120

1 reference

12 July 2018

page(s)

486

1 reference

12 July 2018

The use of oxytetracycline in preventing or delaying isoniazid resistance in pulmonary tuberculosis; a report to the Research Committee of the Tuberculosis Society of Scotland.

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1992755

[A new antituberculotic drug active against isoniazid-resistant bacteria: alpha-ethylisonicotinic acid thioamide; experimental study].

15 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1992755

Viomycin with oxytetracycline in the treatment of pulmonary tuberculosis

12 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13629027

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Preparation of new pyridinic thioamides active in experimental tuberculosis]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13629027

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.1.5120.486

1 reference

12 July 2018

PMC publication ID

1992755

1 reference

12 July 2018

PubMed publication ID

13629027

1 reference

12 July 2018